Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Lancet (London, England)
|
March 19, 2018
Open letter to The Global Fund about its decision to end DPRK grants
Kee B Park, Uzma Khan, Kwonjune Seung
Emerging Infectious Diseases
|
June 14, 2008
Extensively drug-resistant tuberculosis, Lesotho
Hind Satti, Kwonjune Seung, Salmaan Keshavjee, et al.
The Lancet. Global Health
|
August 9, 2014
Strengthening of primary-care delivery in the developing world: IMAI and the need for integrated models of care
Ashwin Vasan, Andrew Ellner, Stephen D Lawn, et al.
BMC Medicine
|
January 16, 2014
Integrated care as a means to improve primary care delivery for adults and adolescents in the developing world: a critical analysis of Integrated Management of Adolescent and Adult Illness (IMAI)
Ashwin Vasan, Andrew Ellner, Stephen D Lawn, et al.
BMC Infectious Diseases
|
August 29, 2016
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial
Meredith Milstein, Leonid Lecca, Charles Peloquin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2023
Estimating post-treatment recurrence after multidrug-resistant tuberculosis treatment among patients with and without HIV: the impact of assumptions about death and missing follow-up
Sara M Sauer, Carole D Mitnick, Uzma Khan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 29, 2023
Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-up
Sara M Sauer, Carole D Mitnick, Uzma Khan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 27, 2026
Comparative effectiveness of three linezolid management strategies for peripheral neuropathy during multidrug- or rifampicin-resistant tuberculosis treatment
Matthew L Romo, Allison LaHood, Carole D Mitnick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 10, 2024
The Frequency and Incidence of QT Prolongation with Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country MDR/RR-TB Cohort
Uzma Khan, Michael Rich, Molly Franke, et al.
The Lancet. Respiratory Medicine
|
March 30, 2018
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis
Federica Fregonese, Shama D Ahuja, Onno W Akkerman, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Lancet (London, England)
|
March 19, 2018
Open letter to The Global Fund about its decision to end DPRK grants
Kee B Park, Uzma Khan, Kwonjune Seung
Emerging Infectious Diseases
|
June 14, 2008
Extensively drug-resistant tuberculosis, Lesotho
Hind Satti, Kwonjune Seung, Salmaan Keshavjee, et al.
The Lancet. Global Health
|
August 9, 2014
Strengthening of primary-care delivery in the developing world: IMAI and the need for integrated models of care
Ashwin Vasan, Andrew Ellner, Stephen D Lawn, et al.
BMC Medicine
|
January 16, 2014
Integrated care as a means to improve primary care delivery for adults and adolescents in the developing world: a critical analysis of Integrated Management of Adolescent and Adult Illness (IMAI)
Ashwin Vasan, Andrew Ellner, Stephen D Lawn, et al.
BMC Infectious Diseases
|
August 29, 2016
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial
Meredith Milstein, Leonid Lecca, Charles Peloquin, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 3, 2023
Estimating post-treatment recurrence after multidrug-resistant tuberculosis treatment among patients with and without HIV: the impact of assumptions about death and missing follow-up
Sara M Sauer, Carole D Mitnick, Uzma Khan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 29, 2023
Estimating Post-treatment Recurrence After Multidrug-Resistant Tuberculosis Treatment Among Patients With and Without Human Immunodeficiency Virus: The Impact of Assumptions About Death and Missing Follow-up
Sara M Sauer, Carole D Mitnick, Uzma Khan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 27, 2026
Comparative effectiveness of three linezolid management strategies for peripheral neuropathy during multidrug- or rifampicin-resistant tuberculosis treatment
Matthew L Romo, Allison LaHood, Carole D Mitnick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 10, 2024
The Frequency and Incidence of QT Prolongation with Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country MDR/RR-TB Cohort
Uzma Khan, Michael Rich, Molly Franke, et al.
The Lancet. Respiratory Medicine
|
March 30, 2018
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis
Federica Fregonese, Shama D Ahuja, Onno W Akkerman, et al.
Page
of 1